Reference

Primary source

MHESI Bio-Cluster Strategic Investment Fund (2025-2030)

~USD 1.5B

As of2025-2030 horizon·Sources1·Primary

Combined matched-funding facility jointly underwritten by Ministry of Higher Education Science Research and Innovation (MHESI), Ministry of Commerce, Ministry of Industry to underwrite BCG-aligned commercial scale-up across the 2025-2030 horizon.

Download CSV ↓Compare plans →

Figure in context

Time scope

2025-2030 horizon

Source basis

Primary source

Interpretation notes

What this tells you

What not to do with it

Use the linked report for interpretation and keep basis differences explicit.

Related figures

Adjacent numbers that add context without drowning the value.

FY2024

~USD 13B

Thailand BCG framework cluster gross output (2024 baseline)

NXPO BCG progress brief, operator disclosures

FY2027 modelled

~USD 24-36B

Thailand BCG framework cluster gross output (2027 base case)

NXPO progress brief, BOI Section 8 BCG pipeline, operator commissioning schedules

2027 cumulative

~USD 1.4-2.2B

Brand-owner Thai-sourced PLA, bio-PE, bio-PET offtake (2027 band)

Coca-Cola, Unilever, Nestle, PepsiCo press releases

2025-2026 commissioning

75 ktpa

NatureWorks-PTTGC Nakhon Sawan PLA plant nameplate capacity

NatureWorks press release, PTTGC factsheet

2027 target

~80%

EECi Wangchan Valley biorefinery cluster 2027 occupancy target

NSTDA EECi Wangchan Valley page

Measure in force 2025-onwards

+5 years

BOI Section 8 BCG Economy bonus additional tax holiday

BOI BCG Economy measures page

Report context

Thailand BCG Bio-Circular Green Economy 2027 Market Intelligence

Thailand's Bio-Circular-Green (BCG) Economy is the country's flagship national industrial strategy, positioning the kingdom as ASEAN's premier biotech, circular-economy, low-carbon production hub. The framework spans four pillars: bio-agriculture (functional food, biopesticides, bio-stimulants), bioenergy (biofuel, biogas, biomass-to-power), biochemicals (lactic, succinic, levulinic acid plus PLA bioplastics), and bioproducts (cosmeceuticals, nutraceuticals, medical-grade). The 2027 catalyst stack is unusually dense: BOI Section 8 BCG Economy bonus (additional 5-year tax holiday plus 50% local-content procurement preference), Eastern Economic Corridor of Innovation (EECi) Wangchan Valley biopharma and biorefinery cluster ramping to 80% occupancy, NSTDA BIOTEC plus Mahidol and KMITL spin-out pipeline (three IPOs targeted by 2027), Coca-Cola, Unilever, Nestle, PepsiCo signing Thailand-sourced PLA, bio-PE, bio-PET offtake reaching USD 1.4-2.2B, the MOST plus MOC plus Industry Ministry Bio-Cluster Strategic Investment Fund (USD 1.5B 2025-2030), the EU-Thailand FTA Bio Annex (signed March 2026) granting Thai PLA, biochemicals 0% tariff into the EU versus 6.5% for China, and T-VER carbon-credit stacking adding 7-12% IRR to bioenergy projects. Base case: 2027 Thai BCG framework cluster gross output reaches USD 24-36B (vs USD 11-15B in 2024), with PTTGC, CPF, Mitr Phol, IVL, ThaiBev, NSTDA BIOTEC, and EECi capturing 70%-plus share. Long-tail of BCG-aligned biotech start-ups and SME bio-processors absorbs the remainder.

Open report →

Atlas actors in this figure's reports

Profiles covered in the report that cite this number.

BIOTEC (NSTDA)

Thai government biotechnology research centre under NSTDA; SPF shrimp broodstock, disease R&D backbone.

Indorama Ventures

World's largest PET producer, integrated polyester, specialty chemicals; FY2024 revenue ~THB 500B+; Lohia family controlled.

Mitr Phol

Largest private Thai sugar producer; Lamsam-family controlled; Thailand, Laos, Cambodia, China, Australia footprint.

PTT Global Chemical

PTT Group downstream petrochemical arm; Map Ta Phut integrated complex, Allnex coatings; FY2024 revenue ~THB 560B.

Time scope	2025-2030 horizon
Sources	MHESI Bio-Cluster Strategic Investment Fund initiative page
Basis	Primary source
Confidence	Primary source